Evidence for Activity of GBR830 (Anti-OX40) in Extrinsic and Intrinsic Atopic Dermatitis (AD) in a Phase 2a Study

2019 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    1
    Citations
    NaN
    KQI
    []